Pancreatic Cancer Research

Digest Map Explore About

Open data from ClinicalTrials.gov, Europe PMC, NIH RePORTER and OpenAlexFor research and education, not medical adviceAbout this project

The Pancreatic Cancer Research Digest

New trials, papers and changes to existing records, compiled daily from the public registries

Monday, July 27, 202610 items · 0 changes to existing records

← Previous day Next day →

New trial

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Why it was picked newest record on or before this date

NCT07492680 ↗ Jul 27, 2026

In this edition

New trials: 1
New papers: 9
New grants: 0
Other new records: 0
Status changes: 0
Results posted: 0
Retractions: 0
Other updates: 0

New paper

ADA2-Functionalized OMVs Remodel the Tumor Microenvironment in Pancreatic Cancer.

Why it was picked newest record on or before this date

DOI 10.3390/pharmaceutics18080920 ↗ Jul 27, 2026

New paper

Trends and Projections of Pancreatic Cancer Mortality Attributable to Smoking and Alcohol Use in the U.S., 1999–2035.

Why it was picked newest record on or before this date

DOI 10.21203/rs.3.rs-10412967/v1 ↗ Jul 27, 2026

New paper

CD73 is associated with glycolysis related metabolic programs and CD8+ T cell suppression in pancreatic ductal adenocarcinoma.

Why it was picked newest record on or before this date

DOI 10.3389/fimmu.2026.1873813 ↗ Jul 27, 2026

New paper

Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

Why it was picked newest record on or before this date

DOI 10.1200/jco-26-00327 ↗ Jul 27, 2026

Also today

New paper

Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19-9 undergoing pancreatic ductal adenocarcinoma resection.

DOI 10.1080/14737140.2026.2699780 ↗ Jul 27, 2026

New paper

Oncogenic Kras targeting with MRTX1133 or Daraxonrasib specifically synergize with anti-CTLA4 to promote anti-tumor immunity in pancreatic cancer.

DOI 10.1038/s41467-026-75960-3 ↗ Jul 27, 2026

New paper

Single-cell and spatial transcriptomics uncover a THBS2⁺ CAF-KRT17⁺ malignant cell axis drives progression and immunotherapy resistance in pancreatic cancer.

DOI 10.1016/j.tranon.2026.102939 ↗ Jul 27, 2026

New paper

Single-cell RNA-seq and spatial transcriptomics characterize CD8+ exhausted T cells in pancreatic ductal adenocarcinoma.

What changed

Change tracking began 4 November 2026, after this day, so only its new records are listed.

Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.

DOI 10.1016/j.isci.2026.116934

·

Jul 27, 2026

New paper

Discovery of a prognostic two-lncRNA panel correlated with immune-associated transcripts for forecasting overall survival in pancreatic cancer.

DOI 10.1016/j.imbio.2026.153221 ↗ Jul 27, 2026